shutterstock_2094533392_michael_vi
Michael Vi / Shutterstock.com
28 February 2023

USPTO told to avoid negative focus on patent thickets

Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
29 October 2026   The Finnish wearable tech company strikes again after the Indian rival’s redesigned ring cleared US Customs, with one of Oura’s asserted patents issued just two days earlier.
MedTech
29 October 2026   Despite earlier wins at the UPC and EPO, a key heart valve patent has been revoked on appeal, with the latest ruling highlighting diverging approaches to patent validity in Europe and raising questions ahead of a separate UPC appeal.
Careers
29 October 2026   The US firm has added a top litigator with experience in pharmaceutical disputes, AI and technology, and complex cross-border litigation, who also made history as the youngest person appointed deputy master of the High Court’s Business and Property Division.